Intrinsic Value of S&P & Nasdaq Contact Us

Adagene Inc. ADAG

NASDAQ Global Market

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
+31.2%

Adagene Inc. (ADAG) current share price is $3.81. The gold spot price is $4,808.10 per troy ounce. Using the formula: ADAG in gold = $3.81 × 31.1035 ÷ $4,808.10 = 0.0246 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of ADAG when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding ADAG shares over the measured period.

ADAG in US Dollars
Gold in US Dollars
ADAG in Gold (grams per share)

Real Wealth Growth Rate

ADAG
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{ADAG}_{\text{gold}}(t) = \frac{P_{\text{ADAG}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{ADAG}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{ADAG}_{\text{gold}}^{(T)}}{\text{ADAG}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{ADAG}_\text{gold}^{(0)}$ = initial gold-price, $\text{ADAG}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

ANAB
ANAB
AnaptysBio, Inc.
$70.22
+2.17%
MLYS
MLYS
Mineralys Therapeutics, Inc.
$27.32
+0.59%
JANX
JANX
Janux Therapeutics, Inc.
$15.24
+2.28%
ELYM
ELYM
Eliem Therapeutics, Inc.
$5.11
-0.97%
RZLT
RZLT
Rezolute, Inc.
$3.56
-1.36%
MOLN
MOLN
Molecular Partners AG
$4.14
-1.66%
ANTX
ANTX
AN2 Therapeutics, Inc.
$2.98
-1.00%
PMVP
PMVP
PMV Pharmaceuticals, Inc.
$1.47
+8.89%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message